{"version":"1.0","provider_name":"Myanmar Newswire","provider_url":"https:\/\/myanmarnewswire.com","author_name":"admin","author_url":"https:\/\/myanmarnewswire.com\/author\/admin\/","title":"AGC Biologics Invests in New Viral Vector Suspension Capabilities at U.S. Cell &amp; Gene Hub - Myanmar Newswire","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"RViRM7OmyK\"><a href=\"https:\/\/myanmarnewswire.com\/agc-biologics-invests-in-new-viral-vector-suspension-capabilities-at-u-s-cell-gene-hub\/\">AGC Biologics Invests in New Viral Vector Suspension Capabilities at U.S. Cell &amp; Gene Hub<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/myanmarnewswire.com\/agc-biologics-invests-in-new-viral-vector-suspension-capabilities-at-u-s-cell-gene-hub\/embed\/#?secret=RViRM7OmyK\" width=\"600\" height=\"338\" title=\"&#8220;AGC Biologics Invests in New Viral Vector Suspension Capabilities at U.S. Cell &amp; Gene Hub&#8221; &#8212; Myanmar Newswire\" data-secret=\"RViRM7OmyK\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n<\/script>\n","description":"New technology and capacity help CDMO\u2019s advanced-therapies campus meet growing market demand SEATTLE, May 17, 2022 (GLOBE NEWSWIRE) \u2014 AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced it is adding viral vector suspension technology and capacity for the development and manufacturing of gene therapies at its commercial-grade campus in [\u2026]"}